Tirzepatide calculator

This is a research reference, not a product for sale or a dosing recommendation. No amount is selected for Tirzepatide. A listed name does not mean it is supplied in a vial or should be injected.

About Tirzepatide

Tirzepatide is a modified 39-amino-acid peptide that activates both the GIP and GLP-1 receptors. Its dual incretin action is studied for effects on glucose regulation, food intake, and body weight. Unlike investigational multi-agonists, tirzepatide is the active ingredient in FDA-approved products for specified indications; regulatory status belongs to those products and labels, not to every preparation sold under the compound name.

At a glance

Class: Dual GIP/GLP-1 receptor agonist; the peptide includes a fatty-diacid modification that supports albumin binding.
Studied mechanism: Activation of GIP and GLP-1 receptors affects glucose-dependent insulin secretion and food intake.
Evidence context: FDA labeling and clinical trials support specific approved tirzepatide products and indications; authorization is not a blanket endorsement of unapproved preparations.

Blank arithmetic calculator

For independently verified inputs, concentration equals entered vial amount in mg divided by added liquid in mL. Entered requested mg divided by concentration gives mL; multiplying mL by the actual syringe markings per mL gives units. Enable JavaScript to use the calculator. This math does not establish that a compound is suitable for injection.

Common questions

How does tirzepatide differ from a GLP-1-only agonist?

Tirzepatide activates both GIP and GLP-1 receptors, while a GLP-1-only agonist targets the GLP-1 receptor.

Is tirzepatide investigational?

Tirzepatide is the active ingredient in FDA-approved products for specific uses. The approval applies to the labeled products and indications, not automatically to other formulations.

Research & references

Related compound pages

Read the math guides · Browse all compound names